[[abstract]]The use of daptomycin has increased in recent years, especially in patients with persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia following vancomycin treatment failure (10)...
Reduced susceptibility to daptomycin in Staphylococcus aureus has now been described, leading to cli...
Reduced susceptibility to daptomycin in Staphylococcus aureus has now been described, leading to cli...
Infections with multidrug-resistant (MDR) gram-positive bacteria are gradually increasing in the wor...
[[abstract]]The use of daptomycin has increased in recent years, especially in patients with persist...
A patient developed a daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) infect...
A patient developed a daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) infect...
from a matched cohort study addressing the clinical conundrum of methicillin-resistant Staphylococcu...
Vancomycin remains the mainstay treatment for methicillin-resistant Staphylococcus aureus (MRSA) blo...
We describe a patient who developed daptomycin-resistant, methicillin-resistant Staphylococcus aureu...
Daptomycin remains as one of the main treatment options for Methicillin-Resistant Staphylococcus aur...
Daptomycin is a novel bactericidal agent active against Gram-positive pathogens including meticillin...
Background. Most cases of reduced vancomycin susceptibility in Staphylococcus aureus reported in the...
Introduction: Infections caused by Methicillin Resistant Staphylococcus aureus (MRSA) are associate...
Reduced susceptibility to daptomycin in Staphylococcus aureus has now been described, leading to cli...
Daptomycin, a new cyclic lipopeptide, was recently approved for the treatment of infections by gram-...
Reduced susceptibility to daptomycin in Staphylococcus aureus has now been described, leading to cli...
Reduced susceptibility to daptomycin in Staphylococcus aureus has now been described, leading to cli...
Infections with multidrug-resistant (MDR) gram-positive bacteria are gradually increasing in the wor...
[[abstract]]The use of daptomycin has increased in recent years, especially in patients with persist...
A patient developed a daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) infect...
A patient developed a daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) infect...
from a matched cohort study addressing the clinical conundrum of methicillin-resistant Staphylococcu...
Vancomycin remains the mainstay treatment for methicillin-resistant Staphylococcus aureus (MRSA) blo...
We describe a patient who developed daptomycin-resistant, methicillin-resistant Staphylococcus aureu...
Daptomycin remains as one of the main treatment options for Methicillin-Resistant Staphylococcus aur...
Daptomycin is a novel bactericidal agent active against Gram-positive pathogens including meticillin...
Background. Most cases of reduced vancomycin susceptibility in Staphylococcus aureus reported in the...
Introduction: Infections caused by Methicillin Resistant Staphylococcus aureus (MRSA) are associate...
Reduced susceptibility to daptomycin in Staphylococcus aureus has now been described, leading to cli...
Daptomycin, a new cyclic lipopeptide, was recently approved for the treatment of infections by gram-...
Reduced susceptibility to daptomycin in Staphylococcus aureus has now been described, leading to cli...
Reduced susceptibility to daptomycin in Staphylococcus aureus has now been described, leading to cli...
Infections with multidrug-resistant (MDR) gram-positive bacteria are gradually increasing in the wor...
DOI
Add to ORKG